NEW YORK, NY / ACCESS Newswire / September 11, 2025 / The New York-based tech company HuCapital has launched the private beta ...

Developing treatments for rare diseases poses many unique challenges that cannot be addressed by traditional study designs. Small populations will result in prolonged enrolment periods and/or ...